Concepedia
Statistics
Publications
72
Citations
5.9K
H-Index
38
Active since
2004
Affiliations
University of Arizona(Current)
Northwestern University
Howard Hughes Medical Institute
University of Pennsylvania
University of California, San Francisco
Chunlong Ma is an author at University of Arizona specializing in pharmacology, virology, and antiviral pharmacology.
Publications per year
2004–2022
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma, M. Sacco, Brett L. Hurst et al. · Cell Research · 2020 · 885 citations · Full text
Pharmacy, Infectious Diseases, Medicinal Chemistry +17
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 399 citations · Full text
Life Sciences, Biochemistry, Medicinal Chemistry +14
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text
Pharmacy, Infectious Diseases, Pharmacology +15
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma, Yanmei Hu, Julia A. Townsend et al. · ACS Pharmacology & Translational Science · 2020 · 272 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus
Jun Wang, Yibing Wu, Chunlong Ma et al. · Proceedings of the National Academy of Sciences · 2013 · 224 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
1–5 of 72